Loading market dashboard
CG Oncology, Inc. Common stock
CGONHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
CG Oncology, Inc. Common stock · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $1.51B | $952.10M - $3.41B | -$1.51B | $6.674 | 6 |
| Dec 2029 | $960.76M | $606.96M - $2.17B | -$960.76M | $3.279 | 11 |
| Dec 2028 | $457.84M | $457.84M - $457.84M | -$457.84M | -$0.126 | 12 |
| Dec 2027 | $87.24M | $62.06M - $127.53M | -$87.24M | -$2.837 | 10 |
| Dec 2026 | $11.05M | $2.36M - $39.94M | -$11.05M | -$2.744 | 11 |
| Dec 2025 | $2.81M | $1.30M - $8.38M | -$2.81M | -$2.176 | 9 |
| Dec 2024 | $1.28M | $409.3K - $2.15M | -$1.28M | -$1.274 | 3 |
| Dec 2023 | $100.8K | $14.9K - $239.0K | -$100.8K | -$1.333 | 4 |